A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response

Cell

Volumn 153, Issue 3, 2013, Pages 601-613

  Ding, Ning ^a   Yu, Ruth T ^a   Subramaniam, Nanthakumar ^c   Sherman, Mara H ^a   Wilson, Caroline ^c   Rao, Renuka ^c   Leblanc, Mathias ^a   Coulter, Sally ^c   He, Mingxiao ^a   Scott, Christopher ^d   Lau, Sue L ^d   Atkins, Annette R ^a   Barish, Grant D ^a   Gunton, Jenny E ^d   Liddle, Christopher ^c   Downes, Michael ^a   Evans, Ronald M ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROGENESIS; GENETIC ASSOCIATION; LIGAND BINDING; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STELLATE CELL; WOUND HEALING;

MUS;

EID: 84876928036     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.03.028     Document Type: Article

References (67)

1. S. Abramovitch, L. Dahan-Bachar, E. Sharvit, Y. Weisman, A. Ben Tov, E. Brazowski, and S. Reif Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats Gut 60 2011 1728 1737
2. N. Agmon-Levin, E. Theodor, R.M. Segal, and Y. Shoenfeld Vitamin D in Systemic and Organ-Specific Autoimmune Diseases Clin. Rev. Allergy Immunol. 2012 2012 14
3. M. Amling, M. Priemel, T. Holzmann, K. Chapin, J.M. Rueger, R. Baron, and M.B. Demay Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses Endocrinology 140 1999 4982 4987
4. M.J. Arthur Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis Am. J. Physiol. Gastrointest. Liver Physiol. 279 2000 G245 G249
5. G.D. Barish, M. Downes, W.A. Alaynick, R.T. Yu, C.B. Ocampo, A.L. Bookout, D.J. Mangelsdorf, and R.M. Evans A Nuclear Receptor Atlas: macrophage activation Mol. Endocrinol. 19 2005 2466 2477
6. G.D. Barish, R.T. Yu, M. Karunasiri, C.B. Ocampo, J. Dixon, C. Benner, A.L. Dent, R.K. Tangirala, and R.M. Evans Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response Genes Dev. 24 2010 2760 2765
7. V. Barry-Hamilton, R. Spangler, D. Marshall, S. McCauley, H.M. Rodriguez, M. Oyasu, A. Mikels, M. Vaysberg, H. Ghermazien, and C. Wai Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment Nat. Med. 16 2010 1009 1017
8. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 218
9. K. Baur, J.C. Mertens, J. Schmitt, R. Iwata, B. Stieger, J.J. Eloranta, P. Frei, F. Stickel, M.T. Dill, and B. Seifert Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients Liver Int. 32 2012 635 643
10. S.C. Biddie, S. John, P.J. Sabo, R.E. Thurman, T.A. Johnson, R.L. Schiltz, T.B. Miranda, M.H. Sung, S. Trump, and S.L. Lightman Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding Mol. Cell 43 2011 145 155
11. A.L. Bookout, Y. Jeong, M. Downes, R.T. Yu, R.M. Evans, and D.J. Mangelsdorf Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network Cell 126 2006 789 799
12. R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H.F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and human health: lessons from vitamin D receptor null mice Endocr. Rev. 29 2008 726 776
13. L. Bouwens, P. De Bleser, K. Vanderkerken, B. Geerts, and E. Wisse Liver cell heterogeneity: functions of non-parenchymal cells Enzyme 46 1992 155 168
14. K. Breitkopf, P. Godoy, L. Ciuclan, M.V. Singer, and S. Dooley TGF-beta/Smad signaling in the injured liver Z. Gastroenterol. 44 2006 57 66
15. A. Chawla, J.J. Repa, R.M. Evans, and D.J. Mangelsdorf Nuclear receptors and lipid physiology: opening the X-files Science 294 2001 1866 1870
16. M. Cohen-Naftaly, and S.L. Friedman Current status of novel antifibrotic therapies in patients with chronic liver disease Therap. Adv. Gastroenterol. 4 2011 391 417
17. N. Ding, H. Zhou, P.O. Esteve, H.G. Chin, S. Kim, X. Xu, S.M. Joseph, M.J. Friez, C.E. Schwartz, S. Pradhan, and T.G. Boyer Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation Mol. Cell 31 2008 347 359
18. X.H. Feng, and R. Derynck Specificity and versatility in tgf-beta signaling through Smads Annu. Rev. Cell Dev. Biol. 21 2005 659 693
19. S.L. Friedman Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies N. Engl. J. Med. 328 1993 1828 1835
20. S.L. Friedman Evaluation of fibrosis and hepatitis C Am. J. Med. 107 6B 1999 27S 30S
21. S.L. Friedman Liver fibrosis - from bench to bedside J. Hepatol. 38 Suppl 1 2003 S38 S53
22. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 88 2008 125 172
23. S.L. Friedman, and M.B. Bansal Reversal of hepatic fibrosis - fact or fantasy? Hepatology 43 2, Suppl 1 2006 S82 S88
24. S.L. Friedman, F.J. Roll, J. Boyles, and D.M. Bissell Hepatic lipocytes: the principal collagen-producing cells of normal rat liver Proc. Natl. Acad. Sci. USA 82 1985 8681 8685
25. M. Gascon-Barré, C. Demers, A. Mirshahi, S. Néron, S. Zalzal, and A. Nanci The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells Hepatology 37 2003 1034 1042
26. A. Geerts History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells Semin. Liver Dis. 21 2001 311 335
27. C.K. Glass, and K. Saijo Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nat. Rev. Immunol. 10 2010 365 376
28. D. Goltzman, D. Miao, D.K. Panda, and G.N. Hendy Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models J. Steroid Biochem. Mol. Biol. 89-90 2004 485 489
29. M.D. Griffin, W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc. Natl. Acad. Sci. USA 98 2001 6800 6805
30. S. Han, T. Li, E. Ellis, S. Strom, and J.Y. Chiang A novel bile acid-activated vitamin D receptor signaling in human hepatocytes Mol. Endocrinol. 24 2010 1151 1164
31. Y.P. Han Matrix metalloproteinases, the pros and cons, in liver fibrosis J. Gastroenterol. Hepatol. 21 Suppl 3 2006 S88 S91
32. S. Heinz, C. Benner, N. Spann, E. Bertolino, Y.C. Lin, P. Laslo, J.X. Cheng, C. Murre, H. Singh, and C.K. Glass Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities Mol. Cell 38 2010 576 589
33. H.F. Hendriks, W.A. Verhoofstad, A. Brouwer, A.M. de Leeuw, and D.L. Knook Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver Exp. Cell Res. 160 1985 138 149
34. V. Hernandez-Gea, and S.L. Friedman Pathogenesis of liver fibrosis Annu. Rev. Pathol. 6 2011 425 456
35. S. Hua, R. Kittler, and K.P. White Genomic antagonism between retinoic acid and estrogen signaling in breast cancer Cell 137 2009 1259 1271
36. Y. Inagaki, and I. Okazaki Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis Gut 56 2007 284 292
37. W. Janssens, C. Mathieu, S. Boonen, and M. Decramer Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle Vitam. Horm. 86 2011 379 399
38. H.M. Kagan, and W. Li Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell J. Cell. Biochem. 88 2003 660 672
39. W.R. Kim, R.S. Brown Jr., N.A. Terrault, and H. El-Serag Burden of liver disease in the United States: summary of a workshop Hepatology 36 2002 227 242
40. D.L. Knook, A.M. Seffelaar, and A.M. de Leeuw Fat-storing cells of the rat liver. Their isolation and purification Exp. Cell Res. 139 1982 468 471
41. U.E. Lee, and S.L. Friedman Mechanisms of hepatic fibrogenesis Best Pract. Res. Clin. Gastroenterol. 25 2011 195 206
42. M.O. Li, and R.A. Flavell TGF-beta: a master of all T cell trades Cell 134 2008 392 404
43. Y.C. Li, A.E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M.B. Demay Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia Proc. Natl. Acad. Sci. USA 94 1997 9831 9835
44. L.Y. Lim, and N. Chalasani Vitamin d deficiency in patients with chronic liver disease and cirrhosis Curr. Gastroenterol. Rep. 14 2012 67 73
45. M. Makishima, T.T. Lu, W. Xie, G.K. Whitfield, H. Domoto, R.M. Evans, M.R. Haussler, and D.J. Mangelsdorf Vitamin D receptor as an intestinal bile acid sensor Science 296 2002 1313 1316
46. J. Massagué TGFbeta in Cancer Cell 134 2008 215 230
47. J. Massagué, J. Seoane, and D. Wotton Smad transcription factors Genes Dev. 19 2005 2783 2810
48. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838
49. S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic actions of vitamin D receptor ligands Endocr. Rev. 26 2005 662 687
50. E. Patsenker, and F. Stickel Role of integrins in fibrosing liver diseases Am. J. Physiol. Gastrointest. Liver Physiol. 301 2011 G425 G434
51. S. Petta, C. Cammà, C. Scazzone, C. Tripodo, V. Di Marco, A. Bono, D. Cabibi, G. Licata, R. Porcasi, G. Marchesini, and A. Craxí Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
52. S.V. Ramagopalan, D.A. Dyment, M.Z. Cader, K.M. Morrison, G. Disanto, J.M. Morahan, A.J. Berlanga-Taylor, A. Handel, G.C. De Luca, and A.D. Sadovnick Rare variants in the CYP27B1 gene are associated with multiple sclerosis Ann. Neurol. 70 2011 881 886
53. H. Reynaert, M.G. Thompson, T. Thomas, and A. Geerts Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension Gut 50 2002 571 581
54. J. Rosenbloom, S.V. Castro, and S.A. Jimenez Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies Ann. Intern. Med. 152 2010 159 166
55. E. Seki, S. De Minicis, C.H. Osterreicher, J. Kluwe, Y. Osawa, D.A. Brenner, and R.F. Schwabe TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat. Med. 13 2007 1324 1332
56. E. Seki, and B. Schnabl Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut J. Physiol. 590 2012 447 458
57. S.V. Siegmund, S. Dooley, and D.A. Brenner Molecular mechanisms of alcohol-induced hepatic fibrosis Dig. Dis. 23 2005 264 274
58. A. Tanaka, S. Nezu, S. Uegaki, K. Kikuchi, A. Shibuya, H. Miyakawa, S. Takahashi, I. Bianchi, P. Zermiani, and M. Podda Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations J. Hepatol. 50 2009 1202 1209
59. B. Terrier, F. Carrat, G. Geri, S. Pol, L. Piroth, P. Halfon, T. Poynard, J.C. Souberbielle, and P. Cacoub Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis J. Hepatol. 55 2011 756 761
60. E. Trompouki, T.V. Bowman, L.N. Lawton, Z.P. Fan, D.C. Wu, A. DiBiase, C.S. Martin, J.N. Cech, A.K. Sessa, and J.L. Leblanc Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration Cell 147 2011 577 589
61. S. Tsukada, C.J. Parsons, and R.A. Rippe Mechanisms of liver fibrosis Clin. Chim. Acta 364 2006 33 60
62. Z. Vadasz, O. Kessler, G. Akiri, S. Gengrinovitch, H.M. Kagan, Y. Baruch, O.B. Izhak, and G. Neufeld Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2 J. Hepatol. 43 2005 499 507
63. M.R. von Essen, M. Kongsbak, P. Schjerling, K. Olgaard, N. Odum, and C. Geisler Vitamin D controls T cell antigen receptor signaling and activation of human T cells Nat. Immunol. 11 2010 344 349
64. R. Williams Global challenges in liver disease Hepatology 44 2006 521 526
65. T.A. Wynn Cellular and molecular mechanisms of fibrosis J. Pathol. 214 2008 199 210
66. L. Xu, A.Y. Hui, E. Albanis, M.J. Arthur, S.M. O'Byrne, W.S. Blaner, P. Mukherjee, S.L. Friedman, and F.J. Eng Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut 54 2005 142 151
67. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, T. Nakatani, H. Tsujinoue, K. Yanase, T. Namisaki, H. Imazu, and H. Fukui Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse Hepatology 36 2002 850 860